604 Page 1 of 8

Form 604

Corporations Act 2001

Section 671B

Notice of change of interests of substantial holder

To Company Name/Scheme
TELIX PHARMACEUTICALS LTD

ACN/ARSN/ABN
616 620 369

Details of substantial holder (1)

Name
JPMorgan Chase & Co. and its affiliates

ACN/ARSN (if applicable)
NA

There was a change in the interests of the substantial holder on
03/June/2026

The previous notice was given to the company on
28/April/2026

The previous notice was dated
24/April/2026

Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:

Class of securities (4)	Previous notice		Present notice
	Person's votes	Voting power (5)	Person's votes	Voting power (5)
Ordinary	34,596,714	10.20%	31,070,240.67	9.16%

Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of change	Person whose relevant interest changed	Nature of change (6)	Consideration given in relation to change (7)	Class and number of securities affected	Person's votes affected
See Appendix	JPMORGAN CHASE BANK, N.A.	Securities on Loan as Agent Lender	See Appendix	4,335,198 (Ordinary)	4,335,198 (Ordinary)
See Appendix	J.P. MORGAN SECURITIES PLC	Holder of securities subject to an obligation to return under a securities lending agreement	See Appendix	397,188 (Ordinary)	397,188 (Ordinary)
See Appendix	J.P. MORGAN SECURITIES PLC	Purchase and sales of securities in its capacity as Principal/Proprietary	See Appendix	876 (Ordinary)	876 (Ordinary)

604 Page 2 of 8
| See Appendix | J.P. MORGAN SECURITIES LLC | Holder of securities subject to an obligation to return under a securities lending agreement | See Appendix | 121,200 (Ordinary) | 121,200 (Ordinary) |
| --- | --- | --- | --- | --- | --- |
| See Appendix | J.P. MORGAN SECURITIES LLC | Purchase and sales of securities in its capacity as Principal/Proprietary | See Appendix | 6,175 (Ordinary) | 6,175 (Ordinary) |
| See Appendix | J.P. MORGAN SECURITIES LLC | Rehypothecation of client securities under a Prime Brokerage Agreement | See Appendix | 26,523 (Ordinary) | 26,523 (Ordinary) |
| See Appendix | J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Holder of securities subject to an obligation to return under a securities lending agreement | See Appendix | 80,712 (Ordinary) | 80,712 (Ordinary) |
| See Appendix | J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Purchase and sales of securities in its capacity as Principal/Proprietary | See Appendix | 594,937 (Ordinary) | 594,937 (Ordinary) |
| See Appendix | J.P. MORGAN PRIME INC. | Rehypothecation of client securities under a Prime Brokerage Agreement | See Appendix | 25 (Ordinary) | 25 (Ordinary) |
| See Appendix | ALMEA 2 SEGREGATED PORTFOLIO COMPANY | Purchase and sales of securities in its capacity as Principal/Proprietary | See Appendix | 74 (Ordinary) | 74 (Ordinary) |
| See Appendix | JPMORGAN ASSET MANAGEMENT (UK) LIMITED | In its capacity as investment manager or in various other related capacities | See Appendix | 16,278 (Ordinary) | 16,278 (Ordinary) |
| See Appendix | JPMORGAN ASSET MANAGEMENT (UK) LIMITED | Securities received as collateral due to securities lending | See Appendix | 662.47 (Ordinary) | 662.47 (Ordinary) |

604 Page 3 of 8

See Appendix	JPMORGAN ASSET MANAGEMENT (SINGAPORE) LIMITED	Securities received as collateral due to securities lending	See Appendix	5.58 (Ordinary)	5.58 (Ordinary)
See Appendix	JPMORGAN ASSET MANAGEMENT (JAPAN) LIMITED	Securities received as collateral due to securities lending	See Appendix	158.36 (Ordinary)	158.36 (Ordinary)
See Appendix	JPMORGAN ASSET MANAGEMENT (ASIA PACIFIC) LIMITED	Securities received as collateral due to securities lending	See Appendix	218.52 (Ordinary)	218.52 (Ordinary)
See Appendix	J.P. MORGAN INVESTMENT MANAGEMENT INC.	Securities received as collateral due to securities lending	See Appendix	121.74 (Ordinary)	121.74 (Ordinary)

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of relevant interest	Registered holder of securities	Person entitled to be registered as holder (8)	Nature of relevant interest (6)	Class and number of securities	Person's votes
JPMORGAN CHASE BANK, N.A.	JPM Nominees Australia Pty Limited	Various Borrowers under the Securities Lending Agreement	Securities on Loan as Agent Lender	6,644,998 (Ordinary)	6,644,998 (Ordinary)
J.P. MORGAN SECURITIES PLC	JPM Nominees Australia Pty Limited	JPM Nominees Australia Pty Limited	Holder of securities subject to an obligation to return under a securities lending agreement	2,602,300 (Ordinary)	2,602,300 (Ordinary)
J.P. MORGAN SECURITIES PLC	JPM Nominees Australia Pty Limited	J.P. MORGAN SECURITIES PLC	Purchase and sales of securities in its capacity as Principal/Proprietary	128,135 (Ordinary)	128,135 (Ordinary)
J.P. MORGAN SECURITIES LLC	Citi Australia	Various Clients and Custodians	Rehypothecation of client securities under a Prime Brokerage Agreement	300,807 (Ordinary)	300,807 (Ordinary)

604 Page 4 of 8
| J.P. MORGAN SECURITIES LLC | Citi Australia | J.P. MORGAN SECURITIES LLC | Purchase and sales of securities in its capacity as Principal/Proprietary | 6,175 (Ordinary) | 6,175 (Ordinary) |
| --- | --- | --- | --- | --- | --- |
| J.P. MORGAN SECURITIES LLC | Citi Australia | Citi Australia | Holder of securities subject to an obligation to return under a securities lending agreement | 2,071,500 (Ordinary) | 2,071,500 (Ordinary) |
| J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Ecapital Nominees Pty Ltd | J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Purchase and sales of securities in its capacity as Principal/Proprietary | 3,062,242 (Ordinary) | 3,062,242 (Ordinary) |
| J.P. MORGAN SECURITIES AUSTRALIA LIMITED | Ecapital Nominees Pty Ltd | Ecapital Nominees Pty Ltd | Holder of securities subject to an obligation to return under a securities lending agreement | 15,986,515 (Ordinary) | 15,986,515 (Ordinary) |
| J.P. MORGAN PRIME INC. | Citi Australia | Various Clients and Custodians | Rehypothecation of client securities under a Prime Brokerage Agreement | 3 (Ordinary) | 3 (Ordinary) |
| ALMEA 2 SEGREGATED PORTFOLIO COMPANY | Various Clients | ALMEA 2 SEGREGATED PORTFOLIO COMPANY | Purchase and sales of securities in its capacity as Principal/Proprietary | 74 (Ordinary) | 74 (Ordinary) |
| J.P. MORGAN INVESTMENT MANAGEMENT INC. | Not Available | Various Clients and Custodians | In its capacity as investment manager or in various other related capacities | 29,623 (Ordinary) | 29,623 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (UK) LIMITED | BNP Paribas (Sydney Branch) | Various Clients and Custodians | In its capacity as investment manager or in various other related capacities | 147,843 (Ordinary) | 147,843 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (UK) LIMITED | Citibank, N.A., Hong Kong Branch | Various Clients and Custodians | In its capacity as investment manager or in various other related capacities | 61,107 (Ordinary) | 61,107 (Ordinary) |
| JPMORGAN CHASE BANK, N.A. | Not Available | Various Clients and Custodians | In its capacity as investment manager or in various other related capacities | 2,336 (Ordinary) | 2,336 (Ordinary) |

604 Page 5 of 8
| J.P. MORGAN SE | Not Available | Various Clients and Custodians | In its capacity as investment manager or in various other related capacities | 25,416 (Ordinary) | 25,416 (Ordinary) |
| --- | --- | --- | --- | --- | --- |
| J.P. MORGAN INVESTMENT MANAGEMENT INC. | J.P. Morgan SE - Luxembourg Branch | J.P. Morgan SE - Luxembourg Branch | Securities received as collateral due to securities lending | 92.09 (Ordinary) | 92.09 (Ordinary) |
| J.P. MORGAN INVESTMENT MANAGEMENT INC. | Brown Brothers Harriman Trustee Services (Ireland ) Limited | Brown Brothers Harriman Trustee Services (Ireland ) Limited | Securities received as collateral due to securities lending | 27.50 (Ordinary) | 27.50 (Ordinary) |
| J.P. MORGAN INVESTMENT MANAGEMENT INC. | JPMIM LONDON-BROKER MESSAGING 1 | JPMIM LONDON-BROKER MESSAGING 1 | Securities received as collateral due to securities lending | 2.15 (Ordinary) | 2.15 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (ASIA PACIFIC) LIMITED | J.P. Morgan SE - Luxembourg Branch | J.P. Morgan SE - Luxembourg Branch | Securities received as collateral due to securities lending | 218.52 (Ordinary) | 218.52 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (JAPAN) LIMITED | J.P. Morgan SE - Luxembourg Branch | J.P. Morgan SE - Luxembourg Branch | Securities received as collateral due to securities lending | 158.36 (Ordinary) | 158.36 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (SINGAPORE) LIMITED | J.P. Morgan SE - Luxembourg Branch | J.P. Morgan SE - Luxembourg Branch | Securities received as collateral due to securities lending | 5.58 (Ordinary) | 5.58 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (UK) LIMITED | J.P. Morgan SE - Luxembourg Branch | J.P. Morgan SE - Luxembourg Branch | Securities received as collateral due to securities lending | 355.04 (Ordinary) | 355.04 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (UK) LIMITED | Brown Brothers Harriman Trustee Services (Ireland ) Limited | Brown Brothers Harriman Trustee Services (Ireland ) Limited | Securities received as collateral due to securities lending | 0.86 (Ordinary) | 0.86 (Ordinary) |
| JPMORGAN ASSET MANAGEMENT (UK) LIMITED | JPMIM LONDON-BROKER MESSAGING 1 | JPMIM LONDON-BROKER MESSAGING 1 | Securities received as collateral due to securities lending | 121.76 (Ordinary) | 121.76 (Ordinary) |

Page 6 of 8

JPMORGAN ASSET MANAGEMENT (UK) LIMITED	JPMorgan Chase Bank - London	JPMorgan Chase Bank - London	Securities received as collateral due to securities lending	165.48 (Ordinary)	165.48 (Ordinary)
JPMORGAN ASSET MANAGEMENT (UK) LIMITED	Not Available	Not Available	Securities received as collateral due to securities lending	19.33 (Ordinary)	19.33 (Ordinary)

*Please note that JPMORGAN CHASE BANK, N.A. also retains a relevant interest in 29,596 of these shares through a proxy voting delegation agreement.

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Subsidiary of JPMorgan Chase & Co.
J.P. MORGAN SECURITIES LLC	Subsidiary of JPMorgan Chase & Co.
J.P. MORGAN SECURITIES PLC	Subsidiary of JPMorgan Chase & Co.
JPMORGAN CHASE BANK, N.A.	Subsidiary of JPMorgan Chase & Co.
J.P. MORGAN PRIME INC.	Subsidiary of JPMorgan Chase & Co.
ALMEA 2 SEGREGATED PORTFOLIO COMPANY	Subsidiary of JPMorgan Chase & Co.
J.P. MORGAN INVESTMENT MANAGEMENT INC.	Subsidiary of JPMorgan Chase & Co.
JPMORGAN ASSET MANAGEMENT (UK) LIMITED	Subsidiary of JPMorgan Chase & Co.
JPMORGAN ASSET MANAGEMENT (ASIA PACIFIC) LIMITED	Subsidiary of JPMorgan Chase & Co.
JPMORGAN ASSET MANAGEMENT (SINGAPORE) LIMITED	Subsidiary of JPMorgan Chase & Co.
JPMORGAN ASSET MANAGEMENT (JAPAN) LIMITED	Subsidiary of JPMorgan Chase & Co.

6. Addresses

The addresses of persons named in this form are as follows:

Name	Address
JPMorgan Chase & Co.	270 Park Avenue, New York, New York, NY, 10017, United States
J.P. MORGAN SECURITIES AUSTRALIA LIMITED	LEVEL 18, 83-85 CASTLEREAGH STREET, SYDNEY, NSW 2000, Australia
J.P. MORGAN SECURITIES LLC	270 Park Avenue, New York, New York, NY, 10017, United States
J.P. MORGAN SECURITIES PLC	25 Bank Street, Canary Wharf, London, E14 5JP, England

604 Page 7 of 8

JPMORGAN CHASE BANK, N.A.	1111 Polaris Parkway, Columbus, Delaware, OH, 43240, United States
J.P. MORGAN PRIME INC.	270 Park Avenue, New York, New York, NY, 10017, United States
ALMEA 2 SEGREGATED PORTFOLIO COMPANY	270 Park Avenue, New York, New York, NY, 10017, United States
J.P. MORGAN INVESTMENT MANAGEMENT INC.	270 Park Avenue, New York, New York, NY, 10017, United States
JPMORGAN ASSET MANAGEMENT (UK) LIMITED	60 Victoria Embankment, London, EC4Y0JP, England
JPMORGAN ASSET MANAGEMENT (ASIA PACIFIC) LIMITED	19 & 20/F, Chater House, 8 Connaught Road Central, Hong Kong, Hong Kong
JPMORGAN ASSET MANAGEMENT (SINGAPORE) LIMITED	88 Market Street, 30-00 CapitaSpring, Singapore, 048948, Singapore
JPMORGAN ASSET MANAGEMENT (JAPAN) LIMITED	Tokyo Building, 7-3 Marunouchi 2 Chome,Chiyoda-ku, Tokyo, 100 6432, Japan
J.P. MORGAN SE	TaunusTurm, Taunustor 1, Frankfurt am Main, Frankfurt, 60310, Germany

Signature

print name	Vasim Pathan	Capacity	Compliance Officer
sign here	VS. Pathan	Date	05/June/2026

604 Page 8 of 8

DIRECTIONS

(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.

(2) See the definition of "associate" in section 9 of the Corporations Act 2001.

(3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

(4) The voting shares of a company constitute one class unless divided into separate classes.

(5) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

(6) Include details of:

(a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

(7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

(8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".

(9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.

1/6

TRADERS FOR RELEVANT PERIOD
Description Date	Cathy	Product Type	Type of Transaction	Price (AUD)	Price (AUD)	Concentration
Balance at start of relevant period				3,699,714
20-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bur	13,700	14.64	84,210.07
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bur	3,120	14.59	45,525.38
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	1620	14.53	915.62
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bur	3,094	14.59	45,130.67
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	13,506	14.59	51,141.94
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	1349	14.90	5,200.07
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	13,094	14.53	44,963.46
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bur	6,263	14.58	91,336.86
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	1387	14.56	2,722.57
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bur	134	14.57	1,345.05
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bur	3,693	14.69	54,250.17
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	1350	14.90	3,334.20
27-Apr-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bur	6,911	14.61	130,213.61
27-Apr-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	13,600	-	-
27-Apr-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	1,400	-	-
27-Apr-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	500	-	-
27-Apr-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	600	-	-
27-Apr-26	J.P. MORGAN SECURITIES PLC	Equity - Depository Receipt	Borrow	600	-	-
27-Apr-26	J.P. MORGAN SECURITIES PLC	Equity - Depository Receipt	Borrow	600	-	-
27-Apr-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow	600	-	-
27-Apr-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow	600	-	-
27-Apr-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow	600	-	-
27-Apr-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow	600	-	-

2/6

TRADES FOR RELEVANT PERIOD
1-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(225)	15.59	$	1,557.75
1-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(14,255)	15.57	$	221,956.35
1-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	174	15.57	$	2,709.18
1-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(14,255)	15.57	$	2,709.18
1-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(562,286)	15.37	$	8,642,316.82
1-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(84)	15.00	$	1,260.00
1-May-26	J.P. MORGAN SECURITIES PLC	Equity	Sell	(40)	15.55	$	622.00
1-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	15,500	15.51	$	246,427.51
1-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(10,100)	-	$	-
1-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(200)	-	$	-
1-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(8,200)	-	$	-
1-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Sell	(1,679)	15.50	$	26,016.14
1-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Sell	(5.65)	15.65	$	5,009.31
1-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(1,007)	-	$	-
1-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(66,400)	-	$	-
1-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(100,000)	-	$	-
1-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	9,065	-	$	-
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	3,060	15.60	$	47,736.00
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,227	15.67	$	19,223.57
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,227	15.75	$	204.75
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(8,654)	15.68	$	125,671.50
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(3,192)	15.98	$	46,723.41
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	3,192	15.61	$	49,820.85
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,080	15.63	$	43,773.41
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	48	15.65	$	751.20
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(173)	15.57	$	2,693.61
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,240)	15.60	$	19,344.00
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	(3,859)	15.62	$	278,950.17
4-May-26	J.P. MORGAN SECURITIES PLC	Equity	Borrow	240,000	-	$	-
4-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow Return	(200,000)	-	$	-
4-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(6,100)	-	$	-
4-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	5,200	-	$	-
4-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	15,59	-	$	32,559.78
4-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(209,751)	-	$	-
4-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(34,902)	-	$	-
4-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	170,000	-	$	-
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(18,513)	15.60	$	288,802.86
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,331)	15.60	$	17,175.60
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,101	15.60	$	17,175.60
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(7,147)	15.42	$	110,278.21
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	7,083	15.43	$	705.50
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	7,083	15.43	$	108,989.66
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(427)	15.48	$	34,350.82
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(604)	15.41	$	9,305.90
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	404	15.51	$	9,369.56
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	38	15.37	$	584.16
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	140	15.44	$	2,161.04
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(48)	15.60	$	748.80
5-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	8,884	15.45	$	131,875.24
5-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(35)	-	$	478.52
5-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	770	15.43	$	11,079.03
5-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(34,300)	-	$	-
5-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(170,000)	-	$	-
5-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(455,000)	-	$	-
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(122)	15.21	$	1,855.62
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	122	15.21	$	1,855.62
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(3,062)	15.21	$	31,363.01
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	3,035	15.43	$	59,105.00
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,014	15.40	$	1,014
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,839	15.32	$	24,937.54
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	48	15.40	$	739.20
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,014)	15.30	$	30,805.87
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(514)	15.32	$	7,875.05
6-May-26	J.P. MORGAN SECURITIES PLC	Equity	Buy	331	15.21	$	3,361.41
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(140)	15.43	$	2,160.25
6-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	4,691	15.36	$	72,050.01
6-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(6,722)	15.14	$	24,951.76
6-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(364,701)	-	$	-
7-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	354,663	15.21	$	5,394,424.23
7-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	627	15.20	$	9,529.75
7-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(627)	14.92	$	9,352.86
7-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1380)	14.84	$	2,274.23
7-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(2,730)	15.09	$	41,195.75
7-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,114	14.81	$	7,168.84
7-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	6,204	14.85	$	95,279.01
7-May-26	J.P. MORGAN SECURITIES	Equity	Buy	2,007	15.09	$	1,777.43
7-May-26	J.P. MORGAN SECURITIES	Equity	Pay	(48)	15.21	$	110.28
7-May-26	J.P. MORGAN SECURITIES	Equity	Pay	(2,730)	15.09	$	41,195.75

3/6

TRADES FOR RELEVANT PERIOD
3-May-26	JP MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(17,400)	-	$
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(115)	14.41	$	1,657.09
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	3,796	14.13	$	53,629.41
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,746)	14.39	$	14,612.04
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(765)	14.36	$	11,268.68
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	396	14.81	$	3,865.32
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	130	14.44	$	1,877.20
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(136)	14.75	$	2,301.09
11-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	3,524	14.60	$	51,452.09
11-May-26	JP. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	15,500	-	$
11-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	1,600	-	$
11-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	2,720	15.10	$	41,080.13
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Sell	(978)	14.99	$	14,662.37
11-May-26	JP MORGAN CHASE BANK, N.A.	Equity	Borrow	67,000	-	$
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(5,139)	14.43	$	74,155.77
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	5,139	14.43	$	74,155.77
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	(5,697)	14.43	$	113,953.71
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(35)	14.81	$	518.23
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(6,238)	14.61	$	120,661.77
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,011	14.44	$	21,113.45
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,391	14.55	$	37,691.14
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,371	14.84	$	20,163.09
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,171	14.34	$	22,157.20
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,182	14.64	$	21,057.05
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	162	14.64	$	1,493.20
12-May-26	J.P. MORGAN SECURITIES	Equity	Sell	(1,371)	14.54	$	2,723.09
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(189)	14.43	$	2,727.27
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	189	14.43	$	2,727.27
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,175	14.35	$	1,943.50
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	12,703	14.57	$	105,087.79
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	14,43	101.01
12-May-26	J.P. MORGAN SECURITIES PLC	Equity	Borrow	5,368	-	$
12-May-26	J.P. MORGAN SECURITIES PLC	Equity	Borrow Return	(5,368)	-	$
12-May-26	J.P. MORGAN SECURITIES PLC	Equity	Borrow	4,632	-	$
12-May-26	J.P. MORGAN SECURITIES PLC	Equity	Borrow Return	(4,632)	-	$
12-May-26	J.P. MORGAN SECURITIES PLC	Equity - Depository Receipt	Borrow Return	(500)	-	$
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(6,300)	-	$
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	8,800	-	$
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	1,426	14.30	$	20,384.85
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Sell	(151)	14.31	$	2,161.55
12-May-26	JP MORGAN CHASE BANK, N.A.	Equity	Borrow Return	-12	-	$
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow	2836	14.44	$	12,069.86
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	4,256	14.57	$	82,008.02
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	55	14.47	$	7,467.86
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(21,771)	14.52	$	316,113.74
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(490)	14.59	$	7,146.88
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(26)	14.52	$	377.54
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	2,511	14.59	$	36,918.96
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	130	14.53	$	420.96
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow	12,222	14.53	$	174.36
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow	12,222	14.53	$	174.36
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow	22,215	14.52	$	322,823.16
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,715)	14.52	$	24,901.80
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(92)	14.52	$	1,335.84
12-May-26	J.P. MORGAN SECURITIES	Equity	Buy	92	14.52	$	1,335.84
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	3,093	14.50	$	30,347.90
12-May-26	JP MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(309,356)	-	$
12-May-26	JP MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(11,828)	-	$
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow Return	24	14.52	$	348.48
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	24	14.52	$	348.48
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	4,609	14.86	$	68,482.69
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,955	14.78	$	28,902.49
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(4,609)	14.87	$	68,557.19
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(578)	14.87	$	6,595.02
12-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	865	14.86	$	12,853.02
12-May-26	J.P. MORGAN SECURITIES	Equity	Sell	(12)	14.52	$	174.24
12-May-26	J.P. MORGAN SECURITIES	Equity	Borrow	14,79	14.79	$	56,990.88
12-May-26	J.P. MORGAN SECURITIES LLC	Equity	Borrow Return	(1,700)	-	$
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(6,300)	-	$
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(2,900)	-	$
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(5,400)	-	$
12-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	1,800	-	$
12-May-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow Return	2,243	-	$
12-May-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow Return	15,08	14.22	$	12,530.93
12-May-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow Return	14,000	-	$
12-May-26	J.P. MORGAN SECURITIES	Equity - Depository Receipt	Borrow Return	14,000	-	$

4/6

TRADES FOR RELEVANT PERIOD
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	706	14.24	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	8,507	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	8,517	14.31	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	115,452	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	115,452	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	115,452	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	158	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	11,891	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	1,927	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	1,937	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	1,937	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	1,937	14.21	$
19-Mar-26	J.P. MORGAN SECURITIES	Equity	Borrow Return	(1,378)
19-Mar-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow Return	(2,046)
19-Mar-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	2	14.34	$
19-Mar-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	166	14.34	$
19-Mar-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(3,083)
19-Mar-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	5,506
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	(10,064)	14.00	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	935	14.14	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	477	14.07	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	(1,418)	14.10	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	14,04	14.04	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	1,423	14.08	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	(5,700)	13.97	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	(5)	14.10	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	1,281	14.10	$
20-Mar-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sut	1,281	14.10	$
20-Mar-26	J.P. MORGAN SECURITIES	Equity	Sut	1,281	14.10	$
20-Mar-26	J.P. MORGAN SECURITIES	Equity	Sut	1,281	14.10	$
20-Mar-26	J.P. MORGAN SECURITIES	Equity	Sut	1,281	14.10	$

5/6

TRADES FOR RELEVANT PERIOD
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	656	13.23	$ 8,078.88
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(3,618)	13.23	$ 47,859.88
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(137)	13.27	$ 1,817.76
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,044	13.25	$ 2,702.14
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	5,303	13.12	$ 43,334.80
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,311	13.12	$ 13,110.20
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(176,644)	13.43	$ 2,372,326.92
26-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	5,379	13.03	$ 70,110.48
26-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	540	13.34	$ 7,205.19
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(13,809)	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	7,723	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	6,086	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	620,000	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	1571	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	5,256	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	21,690	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(8,951)	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(6,506)	-	$ -
26-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(869,794)	-	$ -
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,481	13.34	$ 19,756.54
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,461)	13.34	$ 19,756.54
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,461)	13.58	$ 19,756.54
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(1,888)	13.36	$ 13,368.00
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	(4,292)	13.90	$ 29,201.45
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,318	13.35	$ 17,595.77
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,487	13.70	$ 20,379.16
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,317	13.70	$ 27,40
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	1,317	13.70	$ 27,40
27-May-26	J.P. MORGAN SECURITIES	Equity	Sell	(1,442)	13.58	$ 29,582.36
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	706	13.62	$ 9,613.90
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(108)	13.58	$ 1,466.64
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	108	13.58	$ 1,466.64
27-May-26	J.P. MORGAN SECURITIES	Equity	Buy	22,801	13.61	$ 311,129.40
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow Return	(3,886)	-	$ -
27-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow	120,000	-	$ -
27-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Sell	(71)	13.62	$ 966.99
27-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Sell	(56)	13.58	$ 760.66
27-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	13.63	$ 13.63	$ 6,117.99
27-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(3,000)	-	$ -
27-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(15,500)	-	$ -
27-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(68,500)	-	$ -
27-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(753,850)	-	$ -
27-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(1,329)	-	$ -
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(2,005)	13.03	$ 26,125.15
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	127	13.03	$ 2,957.81
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(227)	13.03	$ 2,957.81
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	2,490	13.14	$ 32,730.95
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(8,977)	13.25	$ 118,941.46
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Sell	(108)	13.66	$ 1,475.40
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	2,163	13.03	$ 28,183.89
28-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow Return	16,159	13.19	$ 136,651.78
28-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	4,100	-	$ -
28-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Borrow	6,100	-	$ -
28-May-26	J.P. MORGAN SECURITIES LLC	Equity - Depository Receipt	Buy	1,144	13.29	$ 15,203.54
28-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow Return	(87,000)	-	$ -
28-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	4,497	-	$ -
28-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	1,346	-	$ -
28-May-26	J.P. MORGAN CHASE BANK, N.A.	Equity	Borrow	51,564	-	$ -
29-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	12,98	-	$ 38.69
29-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	12,98	-	$ 259.80
29-May-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Buy	12,98	-	$ 259.80
29-May-26	J.P. MORGAN SECURITIES	Equity	Sell	(7,371)	13.03	$ 96,044.13
29-May-26	J.P. MORGAN SECURITIES	Equity	Sell	(7,701)	13.03	$ 100,344.03
29-May-26	J.P. MORGAN SECURITIES	Equity	Buy	1,701	13.03	$ 100,344.03
29-May-26	J.P. MORGAN SECURITIES	Equity	Buy	1,701	13.03	$ 6,163.19
29-May-26	J.P. MORGAN SECURITIES	Equity	Buy	473	13.03	$ 7,518.31
29-May-26	J.P. MORGAN SECURITIES	Equity	Buy	473	13.03	$ 7,518.31
29-May-26	J.P. MORGAN SECURITIES	Equity	Buy	1,777	13.03	$ 7,518.31
29-May-26	J.P. MORGAN SECURITIES	Equity	Borrow Return	(17,777)	13.03	$ 7,518.31
29-May-26	J.P. MORGAN SECURITIES	Equity	Borrow Return	(17,777)	13.03	$ 7,518.31

6/6

TRADES FOR RELEVANT PERIOD						Appendix
1-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	149,0851	-	X
1-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	121,6901	-	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	13	13.05	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	113	13.05	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	17121	12.73	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	712	12.73	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	11921	12.68	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	192	12.68	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	6,378	12.63	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	16,7951	12.97	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	1461	13.07	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	3931	13.04	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	263	13.04	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	12,601	12.75	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	11951	12.75	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	15301	12.73	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	334	12.63	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	3,775	12.64	X
2-Jun-26	J.P. MORGAN SECURITIES PLC	Equity	Borrow	500,000	-	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow Return	1,133,000	-	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow Return	1,200,000	-	X
2-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Borrow Return	1,500,000	-	X
2-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Salt	11,2121	12.79	X
2-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Bus	38	12.74	X
2-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	13471	-	X
2-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	14,5931	-	X
2-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	1,243,053	-	X
2-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	1,129,410	-	X
2-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	1,461,000	-	X
2-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow Return	15,3361	-	X
2-Jun-26	JPMORGAN CHASE BANK, N.A.	Equity	Borrow	14,233	-	X
3-Jun-26	J.P. MORGAN PROTE INC.	Equity - Depository Receipt	On-Land Return	(25)	-	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity	On-Land Return	19,3711	-	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	On-Land	35,894	-	X
3-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	16	12.28	X
3-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	13,6171	12.23	X
3-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Bus	3,605	12.22	X
3-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	1,284	12.25	X
3-Jun-26	J.P. MORGAN SECURITIES AUSTRALIA LIMITED	Equity	Salt	1,284	12.25	X
3-Jun-26	J.P. MORGAN SECURITIES LU	Equity - Depository Receipt	Borrow Return	124,300	-	X
3-Jun-26	J.P. MORGAN SECURITIES LU	Equity - Depository Receipt	Borrow Return	1500	-	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Borrow Return	1300	-	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Borrow Return	1200	-	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Borrow Return	1200	-	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	B. 12.28	X	7,786.50	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	B. 12.28	X	787.31	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Bus	53	12.27	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Bus	53	12.28	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Salt	12,28	12,257.06	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	Salt	12,30	12.26	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	B. 12.30	X	12.30	X
3-Jun-26	J.P. MORGAN SECURITIES LIC	Equity - Depository Receipt	B. 12.30	X	12.30	X

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Overseas Securities Lending Agreement ("OSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Barclays Capital Securities Limited ("Borrower")
Transfer date	Settlement date
31-Mar-2026
02-Apr-2026
07-Apr-2026
13-Apr-2026
14-Apr-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4(B)(vi) of the standard form OSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and BNP Paribas Financial Markets (Borrower)
Transfer date	Settlement Date
06-Sep-2024
19-Sep-2024
23-Sep-2024
02-Oct-2024
08-Oct-2024
31-Mar-2025
01-Apr-2025
02-Apr-2025
10-Apr-2025
07-May-2025
09-May-2025
02-Jun-2025
06-Jun-2025
18-Jun-2025
17-Jul-2025
21-Jul-2025
23-Jul-2025
24-Jul-2025
01-Aug-2025
15-Aug-2025
28-Aug-2025
16-Sep-2025
18-Sep-2025
19-Sep-2025
22-Sep-2025
21-Oct-2025
23-Oct-2025
28-Nov-2025
03-Dec-2025
04-Dec-2025
12-Dec-2025
22-Dec-2025
23-Dec-2025
24-Dec-2025
09-Jan-2026
15-Jan-2026
27-Jan-2026
29-Jan-2026
30-Jan-2026
03-Feb-2026
04-Feb-2026
05-Feb-2026
06-Feb-2026
09-Feb-2026

| | 10-Feb-2026
11-Feb-2026
13-Feb-2026
16-Feb-2026
17-Feb-2026
18-Feb-2026
20-Feb-2026
05-Mar-2026
06-Mar-2026
11-Mar-2026
17-Mar-2026
18-Mar-2026
27-Mar-2026
31-Mar-2026
13-Apr-2026
30-Apr-2026
21-May-2026
26-May-2026 |
| --- | --- |
| Holder of voting rights | Borrower |
| Are there any restriction on voting rights | Yes |
| If yes, detail | The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 6.6 of the standard form GMSLA. |
| Scheduled return date (if any) | None |
| Does the borrower have the right to return early? | Yes |
| If yes, detail | Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions. |
| Does the lender have the right to recall early? | Yes |
| If yes, detail | Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions. |
| Will the securities be returned on settlement? | Yes |
| If yes, detail any exceptions | No exceptions |
| Statement | If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC. |

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Master Securities Lending Agreement ("MSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Bofa Securities, Inc. ("Borrower")
Transfer date	Settlement date
24-Mar-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out as per the rights of the borrower as stated in the MSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Citigroup Global Markets Limited (Borrower)
Transfer date	Settlement Date
21-Jan-2026
22-Jan-2026
27-Jan-2026
04-Feb-2026
05-Feb-2026
17-Feb-2026
19-Feb-2026
23-Feb-2026
25-Feb-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 6.6 of the standard form GMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Master Securities Lending Agreement ("MSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Goldman Sachs & Co. LLC ("Borrower")
Transfer date	Settlement Date
28-May-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out as per the rights of the borrower as stated in the MSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Australian Master Securities Lending Agreement ("AMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Macquarie Bank Limited(Borrower)
Transfer date	Settlement Date
05-Jun-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4.3 of the standard form AMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Australian Master Securities Lending Agreement ("AMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Merrill Lynch Equities (Australia) Limited(Borrower)
Transfer date	Settlement Date
31-Mar-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4.3 of the standard form AMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Merrill Lynch International(Borrower)
Transfer date	Settlement Date
24-Mar-2026
16-Apr-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 6.6 of the standard form GMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Morgan Stanley & Co. International PLC (Borrower)
Transfer date	Settlement Date
10-Feb-2026
25-Feb-2026
26-Feb-2026
05-Mar-2026
06-Mar-2026
17-Mar-2026
20-Mar-2026
01-Apr-2026
02-Apr-2026
09-Apr-2026
14-Apr-2026
01-Jun-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 6.6 of the standard form GMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions

Statement

If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Master Securities Lending Agreement ("MSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Morgan Stanley & Co. LLC ("Borrower")
Transfer date	Settlement Date
23-Mar-2026
16-Apr-2026
20-Apr-2026
21-Apr-2026
29-Apr-2026
30-Apr-2026
08-May-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out as per the rights of the borrower as stated in the MSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Australian Master Securities Lending Agreement ("AMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and Morgan Stanley Australia Securities Limited (Borrower)
Transfer date	Settlement Date
25-Feb-2026
03-Mar-2026
04-Jun-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4.3 of the standard form AMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending arrangement disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Australian Master Securities Lending Agreement ("AMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") and UBS Securities Australia Ltd (Borrower)
Transfer date	Settlement Date
01-May-2026
25-May-2026
26-May-2026
05-Jun-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4.3 of the standard form AMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Australian Master Securities Lending Agreement
Parties to agreement	J.P. Morgan Securities Australia Limited ("borrower") and Elk River Holdings Pty Ltd as trustee of Behrenbruch Family Trust ('lender')
Transfer date	Settlement Date
16-Apr-2026
Holder of voting rights	If voting rights arise, Lender may terminate the Loan and recall Securities by giving not less than 10 Business Days' notice to Borrower. The Securities may be re-borrowed by the Borrower immediately following the record date.
Are there any restriction on voting rights	Yes
If yes, detail	The borrower shall have no obligation to arrange for voting rights to be exercised in accordance with the instructions of the other party, unless otherwise agreed between the parties.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery on a business day if notice of redelivery has been given within the standard market settlement period.
Does the lender have the right to recall early?	Yes.
If yes, detail	Lender may call for re-delivery by giving 10 Business Days' notice if proposed issuance of bonds has not occurred on or before 14 Apr 2026, the date on which the bonds are redeemed or converted in full, or 11 months have passed after the securities are borrowed.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Australian Master Securities Lending Agreement ("AMSLA")
Parties to agreement	Citibank N.A. as agent ("lender"), J.P. Morgan Securities Australia Limited ("borrower")
Transfer date	Settlement Date
05-Feb-2026
26-Feb-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavours to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavours to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4.3 of the standard form AMSLA
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any securities or equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities on any business day by giving such notice as agreed by the parties. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Australian Master Securities Lending Agreement ("AMSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender"), J.P. Morgan Securities Australia Limited ('borrower')
Transfer date	Settlement Date
21-Jan-2026
16-Feb-2026
27-Feb-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavours to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavours to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4.3 of the standard form AMSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any securities or equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities on any business day by giving such notice as agreed by the parties. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exception
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	State Street Bank and Trust Company ("lender") and J.P. Morgan Securities Australia Limited ("borrower")
Transfer date	Settlement Date
29-May-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower shall have no obligation to arrange for voting rights to be exercised in accordance with the instructions of the other party, unless otherwise agreed between the parties.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities on any business day by giving such notice as agreed by the parties. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Institutional Account Agreement
Parties to agreement	JP Morgan Securities LLC for itself and as agent and trustee for the other J.P. Morgan Entities and VANGUARD GROUP INC (AS AGT), APEX CLEARING CORPORATION, TRADESTATION SECURITIES INC, ROBINHOOD SECURITIES, LLC, NATIONAL FINANCIAL SERVICES LLC - AS AGENT, NATIONAL FINANCIAL SERVICES LLC, INTERACTIVE BROKERS LLC, VELOCITY CLEARING, LLC, CHARLES SCHWAB & CO., INC, JPMORGAN CHASE BANK, AS AGENT, PERSHING LLC (herein referred to as "JPMS").
"J.P. Morgan Entities" means, as the context may require or permit, any and all of JPMSL, JPMorgan Chase Bank, N.A., J.P. Morgan Securities LLC., J.P. Morgan Markets Limited, J.P. Morgan Securities Australia Limited, J.P. Morgan Securities (Asia Pacific) Limited, J.P. Morgan Securities Japan Co., Ltd and J.P. Morgan Prime Nominees Limited and any additional entity notified to the Company from time to time.
Transfer date	Settlement Date
05-Mar-2026
12-Mar-2026
16-Mar-2026
17-Mar-2026
20-Mar-2026
23-Mar-2026
24-Mar-2026
25-Mar-2026
01-Apr-2026
08-Apr-2026
10-Apr-2026
14-Apr-2026
20-Apr-2026
27-Apr-2026
30-Apr-2026
04-May-2026
11-May-2026
12-May-2026
14-May-2026
28-May-2026
Holder of voting rights	JPMS is the holder of the voting rights from the time at which it exercises its right to borrow. Notwithstanding this, please note that the Company has the right to recall equivalent securities if it wishes to exercise its voting rights in respect of the securities.
Are there any restriction on voting rights	Yes
If yes, detail	JPMS will not be able to exercise voting rights in circumstances where the Company has recalled equivalent securities from JPMS before the voting rights have been exercised. In these circumstances, JPMS must return the securities to the Company and the Company holds the voting rights.
Scheduled return date (if any)	N/A. There is no term to the loan of securities.

Does the borrower have the right to return early?	Yes.
If yes, detail	JPMS has the right to return all and any securities or equivalent securities early at any time.
Does the lender have the right to recall early?	Yes.
If yes, detail	The Company has the right to recall all or any equivalent securities on demand.
Will the securities be returned on settlement?	Yes. Settlement of the loan will occur when JPMS returns equivalent securities to the Company. There is no term to the loan of securities.
If yes, detail any exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	BANK JULIUS BAER & CO. AG vs JPMS PLC
Transfer date	Settlement Date
20-Nov-2025
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower shall have no obligation to arrange for voting rights to be exercised in accordance with the instructions of the other party, unless otherwise agreed between the parties.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery on a business day if notice of redelivery has been given within the standard market settlement period.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time provided notification is given by the lender within standard market settlement period for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Overseas Securities Lender's Agreement ("OSLA")
Parties to agreement	J.P. Morgan Securities Plc ("borrower") and Citibank N.A. acting as Agent ("lender")
Transfer date	Settlement Date
25-Feb-2026
06-May-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavours to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavours to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4(B)(vi) of the standard form OSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities

	were originally delivered. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	J.P. Morgan Securities Plc ("borrower") and Citigroup Global Markets Limited ("lender")
Transfer date	Settlement Date
23-Apr-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower shall have no obligation to arrange for voting rights to be exercised in accordance with the instructions of the other party, unless otherwise agreed between the parties.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, J.P. Morgan Securities Plc will give a copy of the GMSLA to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	HSBC Bank plc (as agent) and J.P. Morgan Securities plc
Transfer date	Settlement Date
08-Oct-2025
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower shall have no obligation to arrange for voting rights to be exercised in accordance with the instructions of the other party, unless otherwise agreed between the parties.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery on a business day if notice of redelivery has been given within the standard market settlement period.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time provided notification is given by the lender within standard market settlement period for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Overseas Securities Lender's Agreement ("OSLA")
Parties to agreement	JPMorgan Chase Bank, N.A. (acting as agent) ("lender") J.P. Morgan Securities plc ("borrower")
Transfer date	Settlement Date
30-Dec-2025
05-Jan-2026
27-Feb-2026
13-Mar-2026
27-Mar-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavors to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavors to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4(B)(vi) of the standard form OSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes

If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered (and where there is a difference between the settlement time for sales and purchases on the relevant exchange or clearing organisation, the standard settlement time shall be the shorter of the two times). The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Master Overseas Securities Borrowing Agreement
Parties to agreement	J.P. Morgan Securities Plc ("borrower") and The Northern Trust Company as agent ("lender")
Transfer date	Settlement Date
04-Jun-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavours to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavours to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is in clause 4(B)(vi) of the agreement.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	J.P. Morgan Securities plc ("borrower") and State St Bank and Trust Company as agent ("lender")
Transfer date	Settlement Date
02-Mar-2026
19-Mar-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower shall have no obligation to arrange for voting rights to be exercised in accordance with the instructions of the other party, unless otherwise agreed between the parties.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery.
Does the lender have the right to recall early?	Yes

If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered. The borrower must return the securities not later than the expiry of such notice in accordance with the lender’s instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Global Master Securities Lending Agreement ("GMSLA")
Parties to agreement	Sharegain Ltd as agent; and J.P. Morgan Securities PLC
Transfer date	Settlement Date
16-Mar-2026
20-Mar-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower shall have no obligation to arrange for voting rights to be exercised in accordance with the instructions of the other party, unless otherwise agreed between the parties.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has the right to terminate a loan and redeliver all and any equivalent securities due and outstanding to the lender in accordance with lender's instructions and lender shall accept such redelivery on a business day if notice of redelivery has been given within the standard market settlement period.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time provided notification is given by the lender within standard market settlement period for such equivalent securities on the exchange or in the clearing organisation through which the relevant borrowed securities were originally delivered. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions..
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions

Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial shareholding notice filed with ASX.

Date:	05-Jun-2026
Company's name:	TELIX PHARMACEUTICALS LTD
ISIN:	AU000000TLX2
Date of change of relevant interests:	03-Jun-2026
Schedule
Type of agreement	Overseas Securities Lender's Agreement ("OSLA")
Parties to agreement	The Bank of New York Mellon Corporation (formerly known as The Bank of New York) (acting as agent) ("lender"), J.P. Morgan Securities Plc ("borrower")
Transfer date	Settlement Date
05-Mar-2026
13-Mar-2026
Holder of voting rights	Borrower
Are there any restriction on voting rights	Yes
If yes, detail	The borrower undertakes to use its best endeavours to arrange for the voting rights to be exercised in accordance with the instructions of the lender, provided that the lender uses its best endeavours to notify the borrower of its instructions in writing no later than 7 business days prior to the date upon which such votes are exercisable or as otherwise agreed between the parties. This undertaking is set out in clause 4(B)(ii) of the standard form OSLA.
Scheduled return date (if any)	None
Does the borrower have the right to return early?	Yes
If yes, detail	Borrower has right to return all and any equivalent securities early at any time in accordance with the lender's instructions.
Does the lender have the right to recall early?	Yes
If yes, detail	Lender has right to recall all or any equivalent securities at any time by giving notice on any business day of not less than the standard settlement time for such equivalent securities on the

	exchange. The borrower must return the securities not later than the expiry of such notice in accordance with the lender's instructions.
Will the securities be returned on settlement?	Yes
If yes, detail any exceptions	No exceptions
Statement	If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a copy of the agreement will be given to that company or ASIC.

AI assistant

Telix Pharmaceuticals Ltd Major Shareholding Notification 2026

31324_rns_2026-06-08_f078a5c8-9778-4dc8-bf0f-099293aaf49f.pdf

4. Present relevant interests

5. Changes in association

6. Addresses

DIRECTIONS

AI assistant

Telix Pharmaceuticals Ltd — Major Shareholding Notification 2026

31324_rns_2026-06-08_f078a5c8-9778-4dc8-bf0f-099293aaf49f.pdf

4. Present relevant interests

5. Changes in association

6. Addresses

DIRECTIONS

More from Telix Pharmaceuticals Ltd

Telix Pharmaceuticals Ltd Major Shareholding Notification 2026